ArticleAntimicrobial agents and chemotherapy2026

Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults.

Jun Morita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.